Results of Endovascular Treatment for Infrapopliteal Arterial Occlusive Disease.

Summary

This study is a prospective, multi-center observational study, which evaluates the effectiveness and safety of endovascular therapy in the real world for infrapopliteal arterial occlusive disease from intermittent claudication to chronic threatening limb ischemia.

Conditions

• Infrapopliteal Artery Occlusive Disease
• Endovascular Treatment

Interventions

DEVICE

Endovascular treatment

Endovascular treatment for infrapopliteal arterial disease.

Sponsors & Collaborators

• Peking University Third Hospital

  collaborator OTHER

• Peking University First Hospital

  collaborator OTHER

• Beijing Hospital

  collaborator OTHER_GOV

• Hospital of Chengdu University of Traditional Chinese Medicine

  collaborator UNKNOWN

• The First Affiliated Hospital of Dalian Medical University

  collaborator OTHER

• Huashan Hospital

  collaborator OTHER

• Shanghai Pudong Hospital

  collaborator OTHER

• Shanghai Zhongshan Hospital

  collaborator OTHER

• The First Affiliated Hospital of Guangzhou Medical University

  collaborator OTHER

• Changhai Hospital

  collaborator OTHER

• Hebei General Hospital

  collaborator OTHER

• Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology

  collaborator OTHER

• LanZhou University

  collaborator OTHER

• The Second Hospital University of South China

  collaborator OTHER

• The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

  collaborator OTHER

• The Affiliated Hospital of Qingdao University

  collaborator OTHER

• Qingdao Haici Hospital

  collaborator OTHER

• Beijing Tsinghua Changgeng Hospital

  collaborator OTHER

• First Hospital of Tsinghua University

  collaborator OTHER

• Shanxi Provincial People's Hospital

  collaborator OTHER_GOV

• Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

  collaborator OTHER

• RenJi Hospital

  collaborator OTHER

• The Luhe Teaching Hospital of the Capital Medical University

  collaborator OTHER

• Beijing Friendship Hospital

  collaborator OTHER

• Second Affiliated Hospital of Soochow University

  collaborator OTHER

• Tianjin First Central Hospital

  collaborator OTHER

• Tianjin Medical University General Hospital

  collaborator OTHER

• Renmin Hospital of Wuhan University

  collaborator OTHER

• First Affiliated Hospital Xi'an Jiaotong University

  collaborator OTHER

• First Affiliated Hospital of Xinjiang Medical University

  collaborator OTHER

• Zhejiang University

  collaborator OTHER

• The First Affiliated Hospital of Zhengzhou University

  collaborator OTHER

• Chinese Academy of Medical Sciences, Fuwai Hospital

  collaborator OTHER

• Xiyuan Hospital of China Academy of Chinese Medical Sciences

  collaborator OTHER

• Xiangya Hospital of Central South University

  collaborator OTHER

• First Affiliated Hospital of Chongqing Medical University

  collaborator OTHER

• Xuanwu Hospital, Beijing

  lead OTHER

Principal Investigators

• Lianrui Guo, M.D. · Xuanwu Hospital, Beijing

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2023-07-01

Primary Completion

2024-10-01

Completion

2025-10-01

Countries

• China

Study Locations